D-0145-2020 Class II Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-0145-2020 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Sep 4, 2019 and is designated Class II. Reason for recall: CGMP Deviation: Presence of dark brown discoloration on edges of tablets. The recall status is terminated (terminated Feb 12, 2020). Affected quantity: 63,216 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 23, 2019
Initiation Date
Sep 4, 2019
Termination Date
Feb 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
63,216 bottles

Product description

Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90

Reason for recall

CGMP Deviation: Presence of dark brown discoloration on edges of tablets.

Distribution pattern

Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.

Code information

Lot # PA218P008, PA218P009, Exp 04/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0145-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0145-2020. Report a data issue: hello@regdatalab.com.